Read + Share
Amedeo Smart
Independent Medical Education
Fuereder T, Minichsdorfer C, Mittlboeck M, Wagner C, et al. Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study. Oral Oncol 2021;124:105634.PMID: 34844042
Email
LinkedIn
Facebook
Twitter
Privacy Policy